PNPLA3 gene variation modulates diet-induced improvement in liver lipid content in type 2 diabetes
Kalliopi Pafili(Düsseldorf University Hospital), Michael Roden(Düsseldorf University Hospital), Bettina Nowotny(Deutsches Diabetes-Zentrum e.V.), Maximilian Huttasch(Deutsches Diabetes-Zentrum e.V.), Klaus Straßburger(Deutsches Diabetes-Zentrum e.V.), Yanislava Karusheva(Deutsches Diabetes-Zentrum e.V.), Oana‐Patricia Zaharia(Düsseldorf University Hospital), Christian Herder(Düsseldorf University Hospital), Alexander Strom(Deutsches Diabetes-Zentrum e.V.), Birgit Knebel(Deutsches Diabetes-Zentrum e.V.), Stefan Kabisch(Deutsches Diabetes-Zentrum e.V.), Julia Szendroedi(Heidelberg University)
Cited by 4
Related Papers
Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets
|Nature Immunology|2023|738
Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?
|Metabolism|2024|137